Compare CPAC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPAC | INMD |
|---|---|---|
| Founded | 1949 | 2008 |
| Country | Peru | Israel |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 848.5M | 842.0M |
| IPO Year | 2003 | 2018 |
| Metric | CPAC | INMD |
|---|---|---|
| Price | $10.65 | $13.81 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 5 |
| Target Price | $12.90 | ★ $17.33 |
| AVG Volume (30 Days) | 44.7K | ★ 685.0K |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.23% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.49 | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | $19.78 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.45 | $12.72 |
| 52 Week High | $11.50 | $16.74 |
| Indicator | CPAC | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 44.27 |
| Support Level | $10.47 | $13.32 |
| Resistance Level | $10.95 | $13.87 |
| Average True Range (ATR) | 0.17 | 0.30 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 59.65 | 42.06 |
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.